KTTA 8-K 2026-08-21

Pasithea Therapeutics Corp. (KTTA) 8-K dated 2026-08-21 — accession 0001213900-26-092672.

Pasithea Therapeutics Corp. (KTTA) is a biotechnology company listed on US.

Pasithea Therapeutics Corp. filed a 8-K on 2026-08-21. Accession 0001213900-26-092672.

This 8-K covers: Listing notice (Item 3.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported KTTA revenue for 2022-12-31 was $486.6K. Net income was -$13.9M. KTTA currently screens at market cap $5.6M.

Not investment advice. The KTTA SEC hub lists recent forms. The stock page is the research view.